Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shaanxi Yisaier Biotechnology is a high-tech enterprise based in Xi'an, China, specializing in the research, development, and clinical application of advanced cell therapies. The company focuses on two primary pillars: immune cell therapy, including CAR-T and NK cells for oncology, and stem cell technology for regenerative medicine and anti-aging. Yisaier operates a comprehensive cell bank and state-of-the-art GMP-standard laboratory facilities to support its pipeline of therapeutic candidates and personalized health management services. Their business model integrates R&D, cell storage, and clinical transformation to address refractory diseases and promote precision medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shaanxi Yisaier Biotechnology.